EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Percutaneous Coronary Interventions: Bleeding Risk Assessment and Management

Adil Salihu iD, David Meier iD, Thabo Mahendiran, Aurelia Zimmerli, Jeremie Buri, Marine Klopfenstein, Emmanuelle Scala, Stephane Fournier

Journal of Clinical Medicine · 22.07.2026 · 15 (14) · 5729

DOI: 10.3390/jcm15145729 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.07.2026. Verfasst von Adil Salihu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bleeding is one of the most common and feared complications after coronary angiography and percutaneous coronary intervention (PCI). It is associated with longer hospital stays, higher mortality, and worse clinical outcomes. As the number of patients at high bleeding risk (HBR) continues to grow, preventing bleeding has become an important part of PCI management. This practical review summarizes current evidence on how to assess bleeding risk and reduce bleeding before, during, and after PCI. Several tools, including the BARC classification, ARC-HBR criteria, PRECISE-DAPT, and DAPT scores, help identify patients who may benefit from tailored treatment. Current strategies include the use of radial access, optimized anticoagulation, appropriate selection of antiplatelet therapy, newer-generation drug-eluting stents, and shorter durations of dual antiplatelet therapy in selected HBR patients. We also discuss the management of patients with atrial fibrillation requiring oral anticoagulation, as well as those with anemia or thrombocytopenia. Although significant progress has been made, several questions remain unanswered, particularly regarding transfusion thresholds, antithrombotic therapy in complex patients, and the best balance between bleeding and ischemic risks. Ongoing clinical trials are expected to provide further evidence and help improve the management of patients undergoing PCI.

Schlagwörter

Stichwörter der Autor:innen

anticoagulation managementblood managementblood transfusionpercutaneous coronary intervention

Autor:innen und Institutionen

  • Department of Cardiology, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland.
  • Department of Anesthesiology, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland.

ORCID-Profile: Adil Salihu, David Meier

Zitieren

APA

Salihu, A., Meier, D., Mahendiran, T., Zimmerli, A., Buri, J., Klopfenstein, M., Scala, E., & Fournier, S. (2026). Percutaneous Coronary Interventions: Bleeding Risk Assessment and Management. Journal of Clinical Medicine, 15(14), 5729. https://doi.org/10.3390/jcm15145729

Vancouver

Salihu A, Meier D, Mahendiran T, Zimmerli A, Buri J, Klopfenstein M, et al. Percutaneous Coronary Interventions: Bleeding Risk Assessment and Management. Journal of Clinical Medicine. 2026;15(14):5729. doi:10.3390/jcm15145729

BibTeX
@article{Salihu2026,
  author = {Salihu, Adil and Meier, David and Mahendiran, Thabo and Zimmerli, Aurelia and Buri, Jeremie and Klopfenstein, Marine and Scala, Emmanuelle and Fournier, Stephane},
  title = {Percutaneous Coronary Interventions: Bleeding Risk Assessment and Management},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {14},
  pages = {5729},
  doi = {10.3390/jcm15145729}
}
Kostenlos starten →